Muscular Dystrophy, Duchenne

"Muscular Dystrophy, Duchenne" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

An X-linked recessive muscle disease caused by an inability to synthesize DYSTROPHIN, which is involved with maintaining the integrity of the sarcolemma. Muscle fibers undergo a process that features degeneration and regeneration. Clinical manifestations include proximal weakness in the first few years of life, pseudohypertrophy, cardiomyopathy (see MYOCARDIAL DISEASES), and an increased incidence of impaired mentation. Becker muscular dystrophy is a closely related condition featuring a later onset of disease (usually adolescence) and a slowly progressive course. (Adams et al., Principles of Neurology, 6th ed, p1415)

Descriptor ID	D020388
MeSH Number(s)	C05.651.534.500.300 C10.668.491.175.500.300 C16.320.322.562 C16.320.577.300
Concept/Terms	Muscular Dystrophy, Duchenne Muscular Dystrophy, Duchenne Cardiomyopathy, Dilated, X-Linked Childhood Muscular Dystrophy, Pseudohypertrophic Childhood Pseudohypertrophic Muscular Dystrophy Duchenne Muscular Dystrophy Duchenne-Type Progressive Muscular Dystrophy Duchenne Type Progressive Muscular Dystrophy Muscular Dystrophy, Childhood, Pseudohypertrophic Muscular Dystrophy, Duchenne Type Muscular Dystrophy, Pseudohypertrophic Pseudohypertrophic Muscular Dystrophy Muscular Dystrophy, Pseudohypertrophic Progressive, Duchenne Type Muscular Dystrophy, Pseudohypertrophic, Childhood Progressive Muscular Dystrophy, Duchenne Type Pseudohypertrophic Childhood Muscular Dystrophy Pseudohypertrophic Muscular Dystrophy, Childhood Cardiomyopathy, Dilated, 3B Duchenne and Becker Muscular Dystrophy Duchenne and Becker Muscular Dystrophy Muscular Dystrophy, Duchenne and Becker Types Duchenne-Becker Muscular Dystrophy Duchenne Becker Muscular Dystrophy Muscular Dystrophy, Duchenne-Becker Becker Muscular Dystrophy Becker Muscular Dystrophy Muscular Dystrophy, Pseudohypertrophic Progressive, Becker Type Muscular Dystrophy, Becker Muscular Dystrophy, Becker Type Becker's Muscular Dystrophy Muscular Dystrophy, Becker's Muscular Dystrophy Pseudohypertrophic Progressive, Becker Type

Below are MeSH descriptors whose meaning is more general than "Muscular Dystrophy, Duchenne".

Diseases [C]
Musculoskeletal Diseases [C05]
Muscular Diseases [C05.651]
Muscular Disorders, Atrophic [C05.651.534]
Muscular Dystrophies [C05.651.534.500]
Muscular Dystrophy, Duchenne [C05.651.534.500.300]
Nervous System Diseases [C10]
Neuromuscular Diseases [C10.668]
Muscular Diseases [C10.668.491]
Muscular Disorders, Atrophic [C10.668.491.175]
Muscular Dystrophies [C10.668.491.175.500]
Muscular Dystrophy, Duchenne [C10.668.491.175.500.300]
Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
Genetic Diseases, Inborn [C16.320]
Genetic Diseases, X-Linked [C16.320.322]
Muscular Dystrophy, Duchenne [C16.320.322.562]
Muscular Dystrophies [C16.320.577]
Muscular Dystrophy, Duchenne [C16.320.577.300]

Below are MeSH descriptors whose meaning is related to "Muscular Dystrophy, Duchenne".

Below are MeSH descriptors whose meaning is more specific than "Muscular Dystrophy, Duchenne".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Muscular Dystrophy, Duchenne" by people in this website by year, and whether "Muscular Dystrophy, Duchenne" was a major or minor topic of these publications.

Bar chart showing 12 publications over 10 distinct years, with a maximum of 2 publications in 2021 and 2022

To see the data from this visualization as text, click here.

Year	Major Topic	Total
2000	1	1
2006	1	1
2008	1	1
2013	1	1
2014	1	1
2015	1	1
2017	1	1
2020	1	1
2021	2	2
2022	2	2

Below are the most recent publications written about "Muscular Dystrophy, Duchenne" by people in Profiles.

Gruber D, Lloyd-Puryear M, Armstrong N, Scavina M, Tavakoli NP, Brower AM, Caggana M, Chung WK. Newborn screening for Duchenne muscular dystrophy-early detection and diagnostic algorithm for female carriers of Duchenne muscular dystrophy. Am J Med Genet C Semin Med Genet. 2022 06; 190(2):197-205.

View in: PubMed
Asma A, Ulusaloglu AC, Shrader MW, Mackenzie WG, Heinle R, Scavina M, Howard JJ. No difference in postoperative complication rates or cardiopulmonary function for early versus late scoliosis correction in Duchenne muscular dystrophy. Spine Deform. 2022 11; 10(6):1429-1436.

View in: PubMed
Sheybani A, Crum K, Raucci FJ, Burnette WB, Markham LW, Soslow JH. Duchenne muscular dystrophy patients: troponin leak in asymptomatic and implications for drug toxicity studies. Pediatr Res. 2022 12; 92(6):1613-1620.

View in: PubMed
Apkon S, Kinnett K, Cripe L, Duan D, Jackson JL, Kornegay JN, Mah ML, Nelson SF, Rao V, Scavina M, Wong BL, Flanigan KM. Parent Project Muscular Dystrophy Females with Dystrophinopathy Conference, Orlando, Florida June 26 - June 27, 2019. J Neuromuscul Dis. 2021; 8(2):315-322.

View in: PubMed
Ryan L, Rahman T, Strang A, Heinle R, Shaffer TH. Diagnostic differences in respiratory breathing patterns and work of breathing indices in children with Duchenne muscular dystrophy. PLoS One. 2020; 15(1):e0226980.

View in: PubMed
Hollin IL, Peay HL, Apkon SD, Bridges JFP. Patient-centered benefit-risk assessment in duchenne muscular dystrophy. Muscle Nerve. 2017 May; 55(5):626-634.

View in: PubMed
Hollin IL, Peay HL, Bridges JF. Caregiver preferences for emerging duchenne muscular dystrophy treatments: a comparison of best-worst scaling and conjoint analysis. Patient. 2015 Feb; 8(1):19-27.

View in: PubMed
Peay HL, Hollin I, Fischer R, Bridges JF. A community-engaged approach to quantifying caregiver preferences for the benefits and risks of emerging therapies for Duchenne muscular dystrophy. Clin Ther. 2014 May; 36(5):624-37.

View in: PubMed
Palladino M, Gatto I, Neri V, Straino S, Smith RC, Silver M, Gaetani E, Marcantoni M, Giarretta I, Stigliano E, Capogrossi M, Hlatky L, Landolfi R, Pola R. Angiogenic impairment of the vascular endothelium: a novel mechanism and potential therapeutic target in muscular dystrophy. Arterioscler Thromb Vasc Biol. 2013 Dec; 33(12):2867-76.

View in: PubMed
Theroux MC, Olivant A, Akins RE. C Histomorphology of neuromuscular junction in Duchenne muscular dystrophy. Paediatr Anaesth. 2008 Mar; 18(3):256-9.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement